Frontlight ResearchEarly access
Trial site
The Oncology Institute of Hope and Innovation
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer1 trial
- Follicular lymphoma1 trial
- Lung cancer1 trial
- Myeloproliferative neoplasms1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 11 trial
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Lead sponsor
- HUYABIO International, LLC.1 trial
- Incyte Corporation1 trial
- Karyopharm Therapeutics Inc1 trial
Running trials
Active, not recruiting
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026